Lung Cancer Trial, Recruiting NCT05059951 Sponsor: Hunan Province Tumor Hospital Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT05059951
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older and have been diagnosed with lung cancer confirmed by a tissue test (biopsy)
  • You have already received chemotherapy, with or without immunotherapy drugs (sometimes called "checkpoint inhibitors")
  • You are in generally good physical condition and able to carry out normal daily activities (this is measured by a standard scale called ECOG, scored 0 or 1 — confirm with trial site)
  • Doctors expect you to live for at least 12 weeks or more
  • Your blood counts and organ function (such as liver and kidneys) are at acceptable levels (confirm with trial site)
  • You have at least one area of cancer that can be measured on a scan, according to standard guidelines
  • You have cancer that has spread to the brain, but it is currently stable (not actively growing or causing new symptoms)

Who may not be able to join:

  • Anyone who does not meet all of the inclusion criteria listed above may not be eligible to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 June 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hunan Province Tumor Hospital
Registry
ClinicalTrials.gov
Start date
3 October 2021
Est. completion
15 September 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Progression-free survival (PFS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov